Jung Ho Kim1 article listing Jung Ho Kim in Nature Communications, indexed by Paperzzz from Crossref and OSF.A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 Nature Communications